Dumfries & Borders

Dumfries & Borders
CEO Julian Howell hails PharmaKrysto's progress. Picture: contributed.

Biopharm firm seals US university tie-up

A biopharmaceutical company based in the Borders has completed an exclusive global licensing deal with a New Jersey university regarding a “potentially revolutionary” treatment for a disease causing kidney stones.

Companies
Load more
Get daily updates Sign Up X